Login to Your Account

Antibiotic Trial to Combine I.V. and Oral Dosing

By Catherine Shaffer
Staff Writer

Tuesday, October 1, 2013
Tetraphase Pharmaceuticals Inc., of Watertown, Mass., shared the design of its planned Phase III trial of eravacycline for complicated urinary tract infections (cUTI), due to begin enrolling in late 2013.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription